AI assistant
Sending…
Compass Therapeutics, Inc. — Director's Dealing 2021
May 5, 2021
32588_dirs_2021-05-05_b15546e2-265c-462d-891b-83846ba4798f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Compass Therapeutics, Inc. (NONE)
CIK: 0001738021
Period of Report: 2021-05-03
Reporting Person: Kalled Susan (Chief Scientific Officer)
More from Compass Therapeutics, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Jan 12
Regulatory Filings
2026
Jan 8
Regulatory Filings
2026
Jan 6
Director's Dealing
2026
Jan 5